ZA9711313B - Stilbene compounds containing an adamantyl-group, compositions containing them and uses thereof. - Google Patents

Stilbene compounds containing an adamantyl-group, compositions containing them and uses thereof.

Info

Publication number: ZA9711313B
Authority: ZA; South Africa
Prior art keywords: adamantyl; group; stilbene compounds; compositions containing; compounds containing
Prior art date: 1996-12-31

Application number

ZA9111313A

Other languages

English (en)

Inventor

Jean-Michel Bernardon

Original Assignee

Oreal

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-31

Filing date

1997-12-17

Publication date

1998-06-23

1997-12-17 Application filed by Oreal filed Critical Oreal

1998-06-23 Publication of ZA9711313B publication Critical patent/ZA9711313B/xx

Links

125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 title 1
239000000203 mixture Substances 0.000 title 1
PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical class C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/30—Compounds having groups
- C07C43/313—Compounds having groups containing halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/30—Compounds having groups
- C07C43/315—Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
- C07C65/28—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups having unsaturation outside the aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Toxicology (AREA)
Biomedical Technology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyridine Compounds (AREA)
Pyrrole Compounds (AREA)
Cosmetics (AREA)

ZA9111313A 1996-12-31 1997-12-17 Stilbene compounds containing an adamantyl-group, compositions containing them and uses thereof. ZA9711313B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9616311A FR2757852B1 (fr)	1996-12-31	1996-12-31	Composes stilbeniques a groupement adamantyl, compositions les contenant et utilisations

Publications (1)

Publication Number	Publication Date
ZA9711313B true ZA9711313B (en)	1998-06-23

Family

ID=9499383

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9111313A ZA9711313B (en)	1996-12-31	1997-12-17	Stilbene compounds containing an adamantyl-group, compositions containing them and uses thereof.

Country Status (16)

Country	Link
US (3)	US6214878B1 (de)
EP (1)	EP0850909B1 (de)
JP (1)	JP2962699B2 (de)
AR (1)	AR009849A1 (de)
AT (1)	ATE199893T1 (de)
AU (1)	AU699626B2 (de)
BR (1)	BR9706311A (de)
CA (1)	CA2224528C (de)
DE (1)	DE69704335T2 (de)
DK (1)	DK0850909T3 (de)
ES (1)	ES2159382T3 (de)
FR (1)	FR2757852B1 (de)
GR (1)	GR3035917T3 (de)
NZ (1)	NZ329462A (de)
PT (1)	PT850909E (de)
ZA (1)	ZA9711313B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2785284B1 (fr) *	1998-11-02	2000-12-01	Galderma Res & Dev	Analogues de la vitamine d
FR2801307B1 (fr) *	1999-11-24	2002-12-06	Galderma Res & Dev	Analogues de la vitamine d
FR2825087B1 (fr) *	2001-05-22	2005-01-14	Galderma Res & Dev	Analogues de la vitamine d
SE0102299D0 (sv) *	2001-06-26	2001-06-26	Astrazeneca Ab	Compounds
SE0102764D0 (sv) *	2001-08-17	2001-08-17	Astrazeneca Ab	Compounds
DE10208955A1 (de) *	2002-02-28	2003-09-11	Bayer Ag	Verfahren zur Herstellung von 2-Halogenalkylnicotinsäuren
US6864264B1 (en)	2002-08-20	2005-03-08	Gloria L. Anderson	1-adamantyl chalcones for the treatment of proliferative disorders
AU2003267346B2 (en)	2002-08-27	2010-06-24	Galderma Research & Development, S.N.C.	Analogues of vitamin D
GB0226930D0 (en)	2002-11-19	2002-12-24	Astrazeneca Ab	Chemical compounds
DE602005013491D1 (de) *	2004-02-18	2009-05-07	Astrazeneca Ab	Benzamidderivate und deren verwendung als glucokinaseaktivierende mittel
KR20070007104A (ko) *	2004-02-18	2007-01-12	아스트라제네카 아베	화합물
TW200600086A (en) *	2004-06-05	2006-01-01	Astrazeneca Ab	Chemical compound
GB0423043D0 (en) *	2004-10-16	2004-11-17	Astrazeneca Ab	Compounds
KR20070085371A (ko)	2004-10-16	2007-08-27	아스트라제네카 아베	페녹시 벤즈아미드 화합물의 제조 방법
GB0423044D0 (en) *	2004-10-16	2004-11-17	Astrazeneca Ab	Compounds
EP1891069A1 (de) *	2005-05-24	2008-02-27	AstraZeneca AB	2-phenylsubstituierte imidazol[4,5b]pyridin/pyrazin- und purinderivate als glucokinasemodulatoren
TW200714597A (en) *	2005-05-27	2007-04-16	Astrazeneca Ab	Chemical compounds
CA2614746C (en) *	2005-07-09	2011-05-10	Astrazeneca Ab	Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
US20080234273A1 (en) *	2005-07-09	2008-09-25	Mckerrecher Darren	Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes
US20110053910A1 (en) *	2005-07-09	2011-03-03	Mckerrecher Darren	2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
US9202182B2 (en) *	2005-08-11	2015-12-01	International Business Machines Corporation	Method and system for analyzing business architecture
TW200738621A (en) *	2005-11-28	2007-10-16	Astrazeneca Ab	Chemical process
EP2045014B8 (de) *	2006-07-25	2014-02-26	National University Corporation Hokkaido University	Polymergestützter metalkomplexkatalysator
TW200825063A (en) *	2006-10-23	2008-06-16	Astrazeneca Ab	Chemical compounds
SA07280576B1 (ar) *	2006-10-26	2011-06-22	استرازينيكا ايه بي	مركبات بنزويل أمينو سيكليل غير متجانسة بأعتبارها عوامل منشطة للجلوكوكيناز
UY30822A1 (es) *	2006-12-21	2008-07-31	Astrazeneca Ab	Fnueva forma cristalina de 3-{[5-azetidin-1-ylcabonyl)pyrazin-2-yl]oxy}-5-[1-methylethyloxy]-n-1h-pyrazol-3-ylbenzamida, composiciones conteniéndola, procesos de preparacion y aplicaciones
FR2910321B1 (fr)	2006-12-21	2009-07-10	Galderma Res & Dev S N C Snc	Gel creme comprenant au moins un retinoide et du peroxyde de benzole
FR2910320B1 (fr)	2006-12-21	2009-02-13	Galderma Res & Dev S N C Snc	Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2931661B1 (fr)	2008-05-30	2010-07-30	Galderma Res & Dev	Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise et un retinoide.
CA2732165A1 (en)	2008-08-04	2010-02-11	Astrazeneca Ab	Therapeutic agents 414
GB0902406D0 (en) *	2009-02-13	2009-04-01	Astrazeneca Ab	Crystalline polymorphic form
GB0902434D0 (en) *	2009-02-13	2009-04-01	Astrazeneca Ab	Chemical process
AR076221A1 (es) *	2009-04-09	2011-05-26	Astrazeneca Ab	Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad
AR076220A1 (es)	2009-04-09	2011-05-26	Astrazeneca Ab	Derivados de pirazol [4,5 - e] pirimidina
WO2016079262A1 (fr) *	2014-11-20	2016-05-26	Galderma Sa	Compositions comprenant un compose de la famille des avermectines et un compose agoniste d'au moins un des recepteurs de l'acide retinoique pour le traitement de l'acne
US10647688B2 (en)	2014-12-19	2020-05-12	Galderma Research & Development	Compounds, synthesis method thereof and use of same in medicine and in cosmetics
WO2021064072A1 (en)	2019-10-02	2021-04-08	INSERM (Institut National de la Santé et de la Recherche Médicale)	Use of retinoic acid receptor (rar) agonists for reversing, preventing, or delaying calcification of aortic valve

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
LU86022A1 (fr)	1985-07-25	1987-02-04	Cird	Derives aromatiques polycyliques,leur procede de preparation et leur application dans les domaines pharmaceutique et cosmetique
DE3926148A1 (de) *	1989-08-08	1991-02-28	Basf Ag	Diarylacetylene, ihre herstellung und verwendung
FR2676052B1 (fr)	1991-05-02	1994-04-29	Cird Galderma	Nouveaux composes polycycliques aromatiques et leur utilisation en medecine humaine ou veterinaire et en cosmetique.
US5436369A (en)	1993-06-16	1995-07-25	Bristol-Myers Squibb Company	Alicyclic phospholipase A2 inhibitors
FR2719044B1 (fr) *	1994-04-26	1996-05-31	Cird Galderma	Nouveaux composés bi-aromatiques acétylénés à groupement adamantyle, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
FR2739557B1 (fr)	1995-10-09	1997-11-14	Cird Galderma	Utilisation d'un ligand agoniste specifique rar-gamma
FR2741876B1 (fr)	1995-12-01	1998-01-09	Cird Galderma	Composes biaromatiques portant un groupement adamantyl en para, compositions pharmaceutiques et cosmetiques les contenant et utilisations
FR2741878B1 (fr) *	1995-12-01	1998-01-09	Cird Galderma	Composes biaromatiques portant un groupement adamantyl en ortho, compositions pharmaceutiques et cosmetiques les contenant et utilisations
US5547893A (en)	1995-12-27	1996-08-20	Vanguard International Semiconductor Corp.	method for fabricating an embedded vertical bipolar transistor and a memory cell
IL127946A0 (en)	1996-07-08	2000-02-17	Cird Galderma	Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents

1996
- 1996-12-31 FR FR9616311A patent/FR2757852B1/fr not_active Expired - Fee Related
1997
- 1997-12-15 ES ES97403043T patent/ES2159382T3/es not_active Expired - Lifetime
- 1997-12-15 AT AT97403043T patent/ATE199893T1/de not_active IP Right Cessation
- 1997-12-15 DK DK97403043T patent/DK0850909T3/da active
- 1997-12-15 PT PT97403043T patent/PT850909E/pt unknown
- 1997-12-15 EP EP97403043A patent/EP0850909B1/de not_active Expired - Lifetime
- 1997-12-15 DE DE69704335T patent/DE69704335T2/de not_active Expired - Fee Related
- 1997-12-17 ZA ZA9111313A patent/ZA9711313B/xx unknown
- 1997-12-18 AU AU48477/97A patent/AU699626B2/en not_active Ceased
- 1997-12-22 NZ NZ329462A patent/NZ329462A/xx unknown
- 1997-12-22 BR BR9706311A patent/BR9706311A/pt not_active Application Discontinuation
- 1997-12-30 AR ARP970106240A patent/AR009849A1/es active IP Right Grant
- 1997-12-30 CA CA002224528A patent/CA2224528C/fr not_active Expired - Fee Related
- 1997-12-31 US US09/002,040 patent/US6214878B1/en not_active Expired - Fee Related
1998
- 1998-01-05 JP JP10000501A patent/JP2962699B2/ja not_active Expired - Fee Related
2001
- 2001-02-21 US US09/788,469 patent/US20020010337A1/en not_active Abandoned
- 2001-05-22 GR GR20010400771T patent/GR3035917T3/el not_active IP Right Cessation
2003
- 2003-10-02 US US10/676,089 patent/US6992095B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AR009849A1 (es)	2000-05-03
US20040067971A1 (en)	2004-04-08
JPH10226667A (ja)	1998-08-25
AU699626B2 (en)	1998-12-10
ES2159382T3 (es)	2001-10-01
US6992095B2 (en)	2006-01-31
PT850909E (pt)	2001-07-31
FR2757852A1 (fr)	1998-07-03
NZ329462A (en)	1999-06-29
DE69704335T2 (de)	2001-07-05
AU4847797A (en)	1998-07-02
CA2224528A1 (fr)	1998-06-30
JP2962699B2 (ja)	1999-10-12
GR3035917T3 (en)	2001-08-31
BR9706311A (pt)	1999-05-18
EP0850909A1 (de)	1998-07-01
MX9710466A (es)	1998-09-30
CA2224528C (fr)	2006-07-18
US6214878B1 (en)	2001-04-10
ATE199893T1 (de)	2001-04-15
DE69704335D1 (de)	2001-04-26
EP0850909B1 (de)	2001-03-21
FR2757852B1 (fr)	1999-02-19
US20020010337A1 (en)	2002-01-24
DK0850909T3 (da)	2001-05-21

Publication	Publication Date	Title
ZA9711313B (en)	1998-06-23	Stilbene compounds containing an adamantyl-group, compositions containing them and uses thereof.
ZA978178B (en)	1998-03-12	Composition.
ZA984849B (en)	1999-12-06	Compositions.
ZA9711092B (en)	1999-07-22	Novel compounds.
EP0621279A3 (de)	1995-01-04	Siloxy-aluminoxan-Zusammensetzungen.
ZA967134B (en)	1997-02-28	Coolant compositions.
ZA964473B (en)	1997-01-29	Endoparasiticidal compositions.
ZA989767B (en)	2000-04-28	Novel compounds.
ZA975261B (en)	1998-03-09	Composition.
ZA973344B (en)	1997-10-20	Antifungal compositions.
ZA9711567B (en)	1998-06-24	Compounds.
ZA9710272B (en)	1998-06-10	Pharmaceutical compositions comprising diaryl-cyclomethylenpyrazole compounds.
EP0674899A3 (de)	1996-11-27	Deodorant.
MX202014B (es)	2001-05-24	Compuestos de estilbeno y su uso.
ZA9510506B (en)	1997-09-11	Anti-oxidant compositions.
ZA9811502B (en)	2000-06-15	Novel composition.
EP0684038A3 (de)	1996-10-30	Desodorisierende Präparate.
ZA975861B (en)	1998-01-30	Bromotiacumicin compounds.
ZA9811503B (en)	2000-06-15	Novel compounds.
ZA9811758B (en)	2000-06-22	Novel compounds.
ZA981164B (en)	1999-08-12	Antiperspirant composition.
ZA979643B (en)	1998-04-28	Heterocyclic compounds, compositions and uses.
ZA979642B (en)	1998-04-28	Heterocyclic compounds, compositions and uses.
ZA200006118B (en)	2002-01-30	Novel composition.
ZA9810585B (en)	2000-05-19	Deodorant composition.